Syndax Pharmaceuticals (SNDX) Net Margin (QoQ) (2015 - 2026)
Syndax Pharmaceuticals (SNDX) Net Margin (QoQ) (2015 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,928.00 |
| Dec 31, 2025 | 4,709.00 |
| Sep 30, 2025 | 6,776.00 |
| Jun 30, 2025 | 22,243.00 |
| Mar 31, 2025 | 80,372.00 |
| Dec 31, 2024 | -55,244.00 |
| Sep 30, 2024 | 147,228.00 |
| Dec 31, 2021 | 24,177.00 |
| Sep 30, 2021 | 589,160.00 |
| Jun 30, 2021 | 126,992.00 |
| Mar 31, 2021 | -199,849.00 |
| Dec 31, 2020 | 2,963.00 |
| Sep 30, 2020 | -82,639.00 |
| Jun 30, 2020 | -44,274.00 |
| Mar 31, 2020 | -71,471.00 |
| Dec 31, 2019 | 41,418.00 |
| Sep 30, 2019 | 60,290.00 |
| Jun 30, 2019 | -45,620.00 |
| Mar 31, 2019 | 68,622.00 |
| Dec 31, 2018 | 8,080.00 |